Sleep Treatments | Sleep Review
Proper use of CPAP therapy can significantly increase sleep apnea patients’ chances of living longer, according to a recent abstract presented at the European Respiratory Society’s (ERS) virtual international congress in 2021 and supported by ResMed.
The ALASKA study, “CPAP Termination and All-Cause Mortality: a French Nationwide Database Analysis” concluded that people with obstructive sleep apnea who continued on PAP (positive airway pressure) therapy were 39% more likely to survive than OSA patients who didn’t. Researchers observed over 176,000 people with sleep apnea in France over a period of three years. Study authors say the gap in survival rate remained significant when the age of the patients, general health, other pre-existing conditions, and causes of death were taken into account.
“Treating sleep apnea with PAP therapy can help you live longer; This is the key to success for people with sleep apnea and their doctors, ”said Adam Benjafield, co-author of the study and vice president of medical affairs for ResMed, in a press release. “This finding underscores the importance of identifying hundreds of millions of people worldwide whose sleep apnea is undiagnosed and treated.”
The ALASKA study was carried out in collaboration with Jean-Louis Pépin; Universities of Grenoble, San Diego, and Sydney; Sameia; and other researchers from ResMed’s industry-academic collaboration medXcloud.